What Is SS-31? Tetrapeptide Identity and Cardiolipin-Binding Mechanism

SS-31 is a synthetic mitochondria-targeting tetrapeptide studied for its capacity to associate with the inner mitochondrial membrane and for the bioenergetic and oxidative-stress endpoints measured in those models. Researchers asking what is SS-31 are usually looking at its structural capacity to bind cardiolipin, a phospholipid central to the integrity of the inner mitochondrial membrane. That property is why the compound appears as a reference tool in cellular-aging, metabolic, and organ-specific ischemia-reperfusion research models.

Mechanism of Action: Targeting Cardiolipin

To characterise what is SS-31, the starting point is its molecular interaction with the inner mitochondrial membrane (IMM). SS-31 (D-Arg-2',6'-Dmt-Lys-Phe-NH₂), also referenced as elamipretide, is an aromatic-cationic tetrapeptide of roughly 639.8 Da that selectively associates with cardiolipin. Cardiolipin is found almost exclusively in the IMM, where it organises the cristae and stabilises electron transport chain (ETC) supercomplexes.

Under experimental stress or elevated reactive oxygen species (ROS) production, cardiolipin undergoes peroxidation. The published account is that this disrupts IMM curvature, collapses mitochondrial membrane potential, and releases cytochrome c into the cytosol. SS-31 associates with cardiolipin through electrostatic and hydrophobic interactions and modulates bilayer surface electrostatics; reported measurements include preserved cristae curvature, higher ATP synthesis efficiency, and reduced electron leak. This is mechanistically distinct from conventional antioxidants, which scavenge ROS after formation — the SS-31 literature describes lower ROS generation upstream instead.

Analytical Identity

| Property | Value | | --- | --- | | Sequence | D-Arg-2',6'-dimethyl-Tyr-Lys-Phe-NH₂ | | Residues | 4 (tetrapeptide) | | Approx. molecular weight | 639.8 Da | | Other identifiers | Elamipretide, Bendavia, MTP-131, SS-31 | | Molecular target | Cardiolipin, inner mitochondrial membrane | | Receptor | None described |

Research Findings in High-Metabolic-Demand Tissue Models

Laboratory work has concentrated on tissues with high mitochondrial density, principally cardiac and renal preparations. In canine cardiac models, reported measurements after chronic exposure include left ventricular function parameters and ventricular remodelling indices alongside restored mitochondrial respiration.

In renal models, SS-31 has been examined against ischemic and metabolic injury endpoints. Because proximal tubules are densely packed with mitochondria, they are a common substrate for this class of experiment; work published in the *Journal of the American Society of Nephrology* reports reduced tubular cell death associated with IMM stabilisation during ischemic intervals. Comparative research designs often place SS-31 alongside other redox-linked research compounds such as NAD+ or glutathione, though its described mitochondrial specificity is distinct.

Neural Model Research

Neural preparations are a growing area of SS-31 study, because neurons depend heavily on mitochondrial ATP for synaptic function. Work in aged murine models reports changes in hippocampal-dependent memory task performance, alongside reduced markers of mitochondrial oxidative stress and neuroinflammation in brain tissue. Research designs frequently examine SS-31 in parallel with MOTS-c, a mitochondrial-derived signalling peptide, to separate biophysical membrane effects from signalling effects in aged cells.

Skeletal Muscle and Exercise-Physiology Models

Skeletal muscle fatigue and age-related muscle loss are closely linked to declining mitochondrial function in animal models. Studies in aged mice report improved muscle function and endurance measurements without a corresponding increase in muscle mass — an outcome the authors attribute to efficiency of existing mitochondria during contractile activity rather than to tissue accretion.

In these experimental contexts SS-31 is sometimes analysed alongside regenerative research peptides such as BPC-157, to test whether mitochondrial stabilisation and tissue-repair signalling register additively in musculoskeletal model endpoints. Reported data on that combination remain preliminary.

Laboratory Handling

SS-31 is typically supplied as a lyophilized (freeze-dried) powder and is highly soluble in sterile water or bacteriostatic saline. As a peptide, it is sensitive to elevated temperature and vigorous agitation, both of which can cause denaturation. Reconstituted solution is generally stored at 2–8°C, protected from light, and used within a short interval; lyophilized material is held at −20°C for long-term storage. Handling parameters should follow the documentation attached to the received batch rather than a generic reference.

Limitations and Open Questions

Several limitations qualify the current record. Most published studies use rodent or canine preparations; mitochondrial function is highly conserved, but pharmacokinetics differ significantly between biological systems. A principal open question concerns long-term IMM stabilisation — a basal level of ROS is required for cellular signalling (mitohormesis), and whether prolonged suppression of mitochondrial ROS interferes with those pathways is unresolved. Cardiolipin density also varies between heart, liver, kidney, and brain, so concentration findings are not directly transferable between tissue types.

Frequently Asked Questions

Q: How does SS-31 differ from standard antioxidants? Standard antioxidants neutralise reactive oxygen species after they have formed. The SS-31 literature describes a different route: association with the inner mitochondrial membrane and preserved electron-transport-chain organisation, with reduced electron leak measured upstream of ROS formation.

Q: What is the primary molecular target of SS-31? Cardiolipin, a tetra-acyl phospholipid of the inner mitochondrial membrane. Reported binding is associated with reduced cardiolipin peroxidation and preserved cristae structure.

Q: Is SS-31 stable at room temperature? In lyophilized form it is relatively stable, though −20°C storage is standard for long-term preservation. Once reconstituted the peptide is more fragile and is kept refrigerated and protected from light.

Q: Does SS-31 cross the blood-brain barrier in animal models? Published animal work reports measurable brain-tissue exposure, which is why neural models appear in the literature. Quantitative transfer between species has not been established.

Q: Where is the analytical documentation? A Janoshik Analytical report dated June 2026 for SS-31 25 mg is on file and displayed with the SS-31 catalog listing, alongside the public batch lookup.

Research Use Only. This content is intended for laboratory and research purposes only. Not for human consumption, diagnosis, or treatment.

Running the numbers for a protocol? Use the research calculators to convert mg, mL, and syringe units.